Related Experiment Videos

Manipulations of cholinesterase gene expression modulate murine megakaryocytopoiesis in vitro

D Patinkin1, S Seidman, F Eckstein

  • 1Department of Biological Chemistry, Hebrew University of Jerusalem, Israel.

Molecular and Cellular Biology
|November 1, 1990
PubMed

Insights

Researchers inhibited megakaryocytopoiesis using a specific oligodeoxynucleotide targeting butyrylcholinesterase mRNA. Recombinant butyrylcholinesterase stimulated this process, implicating the enzyme in bone marrow development.

Area of Science:

  • Hematology
  • Molecular Biology
  • Developmental Biology

Background:

  • Megakaryocytopoiesis is the process of megakaryocyte development, crucial for platelet production.
  • Butyrylcholinesterase (BChE) is an enzyme with various physiological roles, but its involvement in hematopoiesis is not well understood.

Purpose of the Study:

  • To investigate the role of butyrylcholinesterase in megakaryocytopoiesis.
  • To explore the potential of oligodeoxynucleotides for modulating bone marrow development.

Main Methods:

  • Selective inhibition of megakaryocytopoiesis in cultured murine bone marrow cells using a 15-mer oligodeoxynucleotide targeting the initiator AUG region of BChE mRNA.
  • Stimulation of megakaryocytopoiesis using conditioned medium from Xenopus oocytes producing recombinant BChE.

Main Results:

  • The oligodeoxynucleotide selectively inhibited megakaryocytopoiesis.
  • Recombinant BChE, produced in Xenopus oocytes, significantly stimulated megakaryocytopoiesis.

Conclusions:

  • Butyrylcholinesterase plays a significant role in regulating megakaryocytopoiesis.
  • Oligodeoxynucleotides targeting BChE mRNA represent a potential therapeutic strategy for modulating bone marrow development.

Related Concept Videos